J. Cerny

发表

Hematological and biochemical studies in calves living over 100 days with the polymethylmethacrylate total artificial heart TNS Brno II.

J. Vašků, J. Černý, J. Nečas, 1986, International Journal of Artificial Organs.

The Heart Prosthesis - Biocompatibility with Living Tissue

J. Vašků, M. Vrbova, E. Urbánek, 1984, The International journal of artificial organs.

Some problems associated with the implantation of a cardiac prosthesis and with early postoperative care in animals with a total artificial heart.

J. Vašků, E. Urbánek, M. Dostál, 1983, Life support systems : the journal of the European Society for Artificial Organs.

150-day survival of a calf with a polymethylmethacrylate total artificial heart: TNS-BRNO-II.

J. Vašků, E. Urbánek, M. Dostál, 1981, Artificial organs.

Mechanisms causing the death of 8 calves surviving with implanted artificial heart from 31 to 173 days.

J. Vašků, E. Urbánek, M. Dostál, 1984, Experimental pathology.

Changes in the serum proteins in calves surviving several months with the total artificial heart (TAH).

J. Vašků, E. Urbánek, M. Dostál, 1983, Life support systems : the journal of the European Society for Artificial Organs.

Prognostic value of the amount of dysfunctional but viablemyocardium in revascularized patients with coronary arterydisease and left ventricular dysfunction

R. Štípal, J. Meluzin, L. Špinarová, 1999 .

Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome

T. Roubíček, D. Wichterle, R. Polášek, 2019, PloS one.

Innervation of atrial stumps in calves living with the TNS-Brno II artificial heart.

J. Vašků, J. Černý, E. Urbánek, 1985, Artificial organs.

Prognostic importance of the quantification of myocardial viability in revascularized patients with coronary artery disease and moderate-to-severe left ventricular dysfunction.

J. Meluzin, L. Špinarová, R. Panovský, 2003, International journal of cardiology.

Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability

J. Krejčí, J. Toman, J. Meluzin, 2003, European journal of heart failure.

Do the presence and amount of dysfunctional but viable myocardium affect the perioperative outcome of coronary artery bypass graft surgery?

J. Meluzin, L. Špinarová, M. Frélich, 1999, International journal of cardiology.

Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study.

R. Štípal, J. Meluzin, L. Špinarová, 1998, Journal of the American College of Cardiology.

Therapy of Venous Hypertension in Calves with Total Artificial Heart (TAH)

J. Vašků, J. Nečas, M. Dostál, 1989, The International journal of artificial organs.

Left Ventricular Lead Electrical Delay Is a Predictor of Mortality in Patients With Cardiac Resynchronization Therapy

J. Kautzner, T. Roubíček, D. Wichterle, 2015, Circulation. Arrhythmia and electrophysiology.